img

Global Dermatology Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dermatology Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
Dermatology Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Dermatology Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Psoriasis and Skin Infections are the major drivers for the industry.
In the US market, the major manufacturers are AbbVie, Johnson & Johnson, Bayer, Galderma, Bristol-Myers Squibb, Novartis, Pfizer, Merz Pharma, Valeant and Leo Pharma.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dermatology Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline
Segment by Type
External Use
Oral
Injection

Segment by Application


Psoriasis
Skin Infections
Acne
Dermatitis
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Dermatology Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Dermatology Drug introduction, etc. Dermatology Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Dermatology Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Market Overview of Dermatology Drug
1.1 Dermatology Drug Market Overview
1.1.1 Dermatology Drug Product Scope
1.1.2 Dermatology Drug Market Status and Outlook
1.2 Global Dermatology Drug Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Dermatology Drug Market Size by Region (2018-2034)
1.4 Global Dermatology Drug Historic Market Size by Region (2018-2024)
1.5 Global Dermatology Drug Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Dermatology Drug Market Size (2018-2034)
1.6.1 North America Dermatology Drug Market Size (2018-2034)
1.6.2 Europe Dermatology Drug Market Size (2018-2034)
1.6.3 Asia-Pacific Dermatology Drug Market Size (2018-2034)
1.6.4 Latin America Dermatology Drug Market Size (2018-2034)
1.6.5 Middle East & Africa Dermatology Drug Market Size (2018-2034)
2 Dermatology Drug Market by Type
2.1 Introduction
2.1.1 External Use
2.1.2 Oral
2.1.3 Injection
2.2 Global Dermatology Drug Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Dermatology Drug Historic Market Size by Type (2018-2024)
2.2.2 Global Dermatology Drug Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Dermatology Drug Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Dermatology Drug Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Dermatology Drug Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Dermatology Drug Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Dermatology Drug Revenue Breakdown by Type (2018-2034)
3 Dermatology Drug Market Overview by Application
3.1 Introduction
3.1.1 Psoriasis
3.1.2 Skin Infections
3.1.3 Acne
3.1.4 Dermatitis
3.1.5 Others
3.2 Global Dermatology Drug Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Dermatology Drug Historic Market Size by Application (2018-2024)
3.2.2 Global Dermatology Drug Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Dermatology Drug Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Dermatology Drug Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Dermatology Drug Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Dermatology Drug Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Dermatology Drug Revenue Breakdown by Application (2018-2034)
4 Dermatology Drug Competition Analysis by Players
4.1 Global Dermatology Drug Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dermatology Drug as of 2022)
4.3 Date of Key Players Enter into Dermatology Drug Market
4.4 Global Top Players Dermatology Drug Headquarters and Area Served
4.5 Key Players Dermatology Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Dermatology Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AbbVie
5.1.1 AbbVie Profile
5.1.2 AbbVie Main Business
5.1.3 AbbVie Dermatology Drug Products, Services and Solutions
5.1.4 AbbVie Dermatology Drug Revenue (US$ Million) & (2018-2024)
5.1.5 AbbVie Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Profile
5.2.2 Johnson & Johnson Main Business
5.2.3 Johnson & Johnson Dermatology Drug Products, Services and Solutions
5.2.4 Johnson & Johnson Dermatology Drug Revenue (US$ Million) & (2018-2024)
5.2.5 Johnson & Johnson Recent Developments
5.3 Bayer
5.3.1 Bayer Profile
5.3.2 Bayer Main Business
5.3.3 Bayer Dermatology Drug Products, Services and Solutions
5.3.4 Bayer Dermatology Drug Revenue (US$ Million) & (2018-2024)
5.3.5 Galderma Recent Developments
5.4 Galderma
5.4.1 Galderma Profile
5.4.2 Galderma Main Business
5.4.3 Galderma Dermatology Drug Products, Services and Solutions
5.4.4 Galderma Dermatology Drug Revenue (US$ Million) & (2018-2024)
5.4.5 Galderma Recent Developments
5.5 Bristol-Myers Squibb
5.5.1 Bristol-Myers Squibb Profile
5.5.2 Bristol-Myers Squibb Main Business
5.5.3 Bristol-Myers Squibb Dermatology Drug Products, Services and Solutions
5.5.4 Bristol-Myers Squibb Dermatology Drug Revenue (US$ Million) & (2018-2024)
5.5.5 Bristol-Myers Squibb Recent Developments
5.6 Novartis
5.6.1 Novartis Profile
5.6.2 Novartis Main Business
5.6.3 Novartis Dermatology Drug Products, Services and Solutions
5.6.4 Novartis Dermatology Drug Revenue (US$ Million) & (2018-2024)
5.6.5 Novartis Recent Developments
5.7 Pfizer
5.7.1 Pfizer Profile
5.7.2 Pfizer Main Business
5.7.3 Pfizer Dermatology Drug Products, Services and Solutions
5.7.4 Pfizer Dermatology Drug Revenue (US$ Million) & (2018-2024)
5.7.5 Pfizer Recent Developments
5.8 Merz Pharma
5.8.1 Merz Pharma Profile
5.8.2 Merz Pharma Main Business
5.8.3 Merz Pharma Dermatology Drug Products, Services and Solutions
5.8.4 Merz Pharma Dermatology Drug Revenue (US$ Million) & (2018-2024)
5.8.5 Merz Pharma Recent Developments
5.9 Valeant
5.9.1 Valeant Profile
5.9.2 Valeant Main Business
5.9.3 Valeant Dermatology Drug Products, Services and Solutions
5.9.4 Valeant Dermatology Drug Revenue (US$ Million) & (2018-2024)
5.9.5 Valeant Recent Developments
5.10 LEO Pharma
5.10.1 LEO Pharma Profile
5.10.2 LEO Pharma Main Business
5.10.3 LEO Pharma Dermatology Drug Products, Services and Solutions
5.10.4 LEO Pharma Dermatology Drug Revenue (US$ Million) & (2018-2024)
5.10.5 LEO Pharma Recent Developments
5.11 GlaxoSmithKline
5.11.1 GlaxoSmithKline Profile
5.11.2 GlaxoSmithKline Main Business
5.11.3 GlaxoSmithKline Dermatology Drug Products, Services and Solutions
5.11.4 GlaxoSmithKline Dermatology Drug Revenue (US$ Million) & (2018-2024)
5.11.5 GlaxoSmithKline Recent Developments
6 North America
6.1 North America Dermatology Drug Market Size by Country (2018-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Dermatology Drug Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Dermatology Drug Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Dermatology Drug Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Dermatology Drug Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Dermatology Drug Market Dynamics
11.1 Dermatology Drug Industry Trends
11.2 Dermatology Drug Market Drivers
11.3 Dermatology Drug Market Challenges
11.4 Dermatology Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Dermatology Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Dermatology Drug Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Dermatology Drug Market Size Share by Region (2018-2024)
Table 4. Global Dermatology Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Dermatology Drug Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Dermatology Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Dermatology Drug Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Dermatology Drug Revenue Market Share by Type (2018-2024)
Table 9. Global Dermatology Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Dermatology Drug Revenue Market Share by Type (2024-2034)
Table 11. North America Dermatology Drug Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Dermatology Drug Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Dermatology Drug Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Dermatology Drug Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Dermatology Drug Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Dermatology Drug Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Dermatology Drug Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Dermatology Drug Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Dermatology Drug Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Dermatology Drug Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Dermatology Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Dermatology Drug Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Dermatology Drug Revenue Market Share by Application (2018-2024)
Table 24. Global Dermatology Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Dermatology Drug Revenue Market Share by Application (2024-2034)
Table 26. North America Dermatology Drug Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Dermatology Drug Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Dermatology Drug Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Dermatology Drug Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Dermatology Drug Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Dermatology Drug Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Dermatology Drug Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Dermatology Drug Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Dermatology Drug Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Dermatology Drug Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Dermatology Drug Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Dermatology Drug Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dermatology Drug as of 2022)
Table 39. Date of Key Players Enter into Dermatology Drug Market
Table 40. Global Dermatology Drug Key Players Headquarters and Area Served
Table 41. Dermatology Drug Product Solution and Service
Table 42. Global Dermatology Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. AbbVie Basic Information List
Table 45. AbbVie Description and Business Overview
Table 46. AbbVie Dermatology Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Dermatology Drug Business of AbbVie (2018-2024)
Table 48. AbbVie Recent Developments
Table 49. Johnson & Johnson Basic Information List
Table 50. Johnson & Johnson Description and Business Overview
Table 51. Johnson & Johnson Dermatology Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Dermatology Drug Business of Johnson & Johnson (2018-2024)
Table 53. Johnson & Johnson Recent Developments
Table 54. Bayer Basic Information List
Table 55. Bayer Description and Business Overview
Table 56. Bayer Dermatology Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Dermatology Drug Business of Bayer (2018-2024)
Table 58. Bayer Recent Developments
Table 59. Galderma Basic Information List
Table 60. Galderma Description and Business Overview
Table 61. Galderma Dermatology Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Dermatology Drug Business of Galderma (2018-2024)
Table 63. Galderma Recent Developments
Table 64. Bristol-Myers Squibb Basic Information List
Table 65. Bristol-Myers Squibb Description and Business Overview
Table 66. Bristol-Myers Squibb Dermatology Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Dermatology Drug Business of Bristol-Myers Squibb (2018-2024)
Table 68. Bristol-Myers Squibb Recent Developments
Table 69. Novartis Basic Information List
Table 70. Novartis Description and Business Overview
Table 71. Novartis Dermatology Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Dermatology Drug Business of Novartis (2018-2024)
Table 73. Novartis Recent Developments
Table 74. Pfizer Basic Information List
Table 75. Pfizer Description and Business Overview
Table 76. Pfizer Dermatology Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Dermatology Drug Business of Pfizer (2018-2024)
Table 78. Pfizer Recent Developments
Table 79. Merz Pharma Basic Information List
Table 80. Merz Pharma Description and Business Overview
Table 81. Merz Pharma Dermatology Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Dermatology Drug Business of Merz Pharma (2018-2024)
Table 83. Merz Pharma Recent Developments
Table 84. Valeant Basic Information List
Table 85. Valeant Description and Business Overview
Table 86. Valeant Dermatology Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Dermatology Drug Business of Valeant (2018-2024)
Table 88. Valeant Recent Developments
Table 89. LEO Pharma Basic Information List
Table 90. LEO Pharma Description and Business Overview
Table 91. LEO Pharma Dermatology Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Dermatology Drug Business of LEO Pharma (2018-2024)
Table 93. LEO Pharma Recent Developments
Table 94. GlaxoSmithKline Basic Information List
Table 95. GlaxoSmithKline Description and Business Overview
Table 96. GlaxoSmithKline Dermatology Drug Products, Services and Solutions
Table 97. Revenue (US$ Million) in Dermatology Drug Business of GlaxoSmithKline (2018-2024)
Table 98. GlaxoSmithKline Recent Developments
Table 99. North America Dermatology Drug Market Size by Country (2018-2024) & (US$ Million)
Table 100. North America Dermatology Drug Market Size by Country (2024-2034) & (US$ Million)
Table 101. Europe Dermatology Drug Market Size by Country (2018-2024) & (US$ Million)
Table 102. Europe Dermatology Drug Market Size by Country (2024-2034) & (US$ Million)
Table 103. Asia-Pacific Dermatology Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 104. Asia-Pacific Dermatology Drug Market Size by Region (2018-2024) & (US$ Million)
Table 105. Asia-Pacific Dermatology Drug Market Size by Region (2024-2034) & (US$ Million)
Table 106. Asia-Pacific Dermatology Drug Market Share by Region (2018-2024)
Table 107. Asia-Pacific Dermatology Drug Market Share by Region (2024-2034)
Table 108. Latin America Dermatology Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 109. Latin America Dermatology Drug Market Size by Country (2018-2024) & (US$ Million)
Table 110. Latin America Dermatology Drug Market Size by Country (2024-2034) & (US$ Million)
Table 111. Middle East & Africa Dermatology Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 112. Middle East & Africa Dermatology Drug Market Size by Country (2018-2024) & (US$ Million)
Table 113. Middle East & Africa Dermatology Drug Market Size by Country (2024-2034) & (US$ Million)
Table 114. Dermatology Drug Market Trends
Table 115. Dermatology Drug Market Drivers
Table 116. Dermatology Drug Market Challenges
Table 117. Dermatology Drug Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dermatology Drug Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Dermatology Drug Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Dermatology Drug Market Share by Regions: 2022 VS 2034
Figure 4. Global Dermatology Drug Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Dermatology Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Dermatology Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Dermatology Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Dermatology Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Dermatology Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of External Use
Figure 11. Global External Use Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of Oral
Figure 13. Global Oral Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of Injection
Figure 15. Global Injection Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Global Dermatology Drug Market Size Share by Type: 2022 & 2034
Figure 17. North America Dermatology Drug Revenue Market Share by Type (2018-2034)
Figure 18. Europe Dermatology Drug Revenue Market Share by Type (2018-2034)
Figure 19. Asia-Pacific Dermatology Drug Revenue Market Share by Type (2018-2034)
Figure 20. Latin America Dermatology Drug Revenue Market Share by Type (2018-2034)
Figure 21. Middle East and Africa Dermatology Drug Revenue Market Share by Type (2018-2034)
Figure 22. Psoriasis Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 23. Skin Infections Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 24. Acne Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 25. Dermatitis Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 26. Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 27. Global Dermatology Drug Market Size Share by Application: 2022 & 2034
Figure 28. North America Dermatology Drug Revenue Market Share by Application (2018-2034)
Figure 29. Europe Dermatology Drug Revenue Market Share by Application (2018-2034)
Figure 30. Asia-Pacific Dermatology Drug Revenue Market Share by Application (2018-2034)
Figure 31. Latin America Dermatology Drug Revenue Market Share by Application (2018-2034)
Figure 32. Middle East and Africa Dermatology Drug Revenue Market Share by Application (2018-2034)
Figure 33. Dermatology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 34. Global Top 5 and Top 10 Players Dermatology Drug Market Share in 2022
Figure 35. North America Dermatology Drug Market Share by Country (2018-2034)
Figure 36. U.S. Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 37. Canada Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 38. Germany Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 39. France Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 40. U.K. Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 41. Italy Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 42. Russia Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 43. Nordic Countries Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 44. Asia-Pacific Dermatology Drug Market Share by Region (2018-2034)
Figure 45. China Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 46. Japan Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 47. South Korea Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 48. Southeast Asia Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 49. India Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 50. Australia Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 51. Latin America Dermatology Drug Market Share by Country (2018-2034)
Figure 52. Mexico Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 53. Brazil Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 54. Middle East & Africa Dermatology Drug Market Share by Country (2018-2034)
Figure 55. Turkey Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 56. Saudi Arabia Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 57. UAE Dermatology Drug Market Size (2018-2034) & (US$ Million)
Figure 58. Bottom-up and Top-down Approaches for This Report